Table 3a.
ROC analysis and Wilcoxin rank-sum test - Pancreatic cancer biomarker candidates.
| Marker candidate | Cancer cases vs non-disease control | Cancer cases vs all controls (non-disease control and chronic pancreatitis) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AUC | Sens at 100% Spec | Sens at 95% Spec | Spec at 100% Sens | Spec at 95% Sens | p value (Wilcoxin rank-sum test) | AUC | Sens at 100% Spec | Sens at 95% Spec | Spec at 100% Sens | Spec at 95% Sens | p value (Wilcoxin rank-sum test) | |
| TIMP1 | 0.83 | 54% | 54% | 22% | 22% | <0.0001 | 0.82 | 38% | 54% | 19% | 21% | <0.0001 |
| ICAM1 | 0.83 | 55% | 65% | 11% | 15% | 0.0001 | 0.80 | 40% | 55% | 7% | 11% | 0.0002 |
| THBS1 | 0.68 | 0% | 0% | 0% | 11% | 0.1600 | 0.70 | 0% | 13% | 0% | 16% | 0.0385 |
| CCL5 | 0.51 | 0% | 0% | 22% | 22% | 1.0000 | 0.61 | 0% | 0% | 6% | 6% | 0.3180 |
| LBP | 0.58 | 12% | 29% | 0% | 0% | 0.4280 | 0.51 | 12% | 18% | 3% | 3% | 0.9284 |
| PPBP | 0.52 | 0% | 0% | 42% | 42% | 0.8709 | 0.61 | 0% | 0% | 42% | 42% | 0.2600 |
| CA19-9 | 0.58 | 0% | 0% | 5% | 5% | 0.4884 | 0.57 | 0% | 8% | 0% | 0% | 0.4750 |